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1. Introduction 
Obesity has a profound impact on the cardiovascular disease development, and is associated 
with a reduced overall survival. There is a strong correlation between the central 
(abdominal) type of obesity and the cardiovascular and metabolic diseases. Among a variety 
of anthropometric measurements of the abdominal fat size, sagittal abdominal diameter has 
been proposed as the valid measurement of the visceral fat mass and cardiometabolic risk 
level. Many studies have analyzed the relationship between sagittal abdominal diameter 
(SAD), visceral fat area, and different markers of cardiometabolic disturbances with respect 
to age, gender and ethnicity. Some of them have offered the cut-off values that could be 
useful in clinical practice, in identifying  individuals who are at higher risk of comorbidities 
of the obesity. Using the principles of rough set theory, based on producing If-Then rules, we 
have developed a model that allows better applicability of SAD in identifying patients at 
higher cardiovascular risk. In this chapter, we describe the basic principles of the proposed 
model. Furthermore, we give a broad overview of the main concerns regarding the 
significance of SAD and its use in diagnosing the abdominal obesity and predicting the 
adverse cardiometabolic outcomes. 
2. Obesity as a cardiovascular risk factor 
The prevalence of obesity has increased dramatically worldwide during the past few decades. 
Obesity is recognized as an independent factor for the development of the cardiovascular 
diseases. It also predisposes to the development of other cardiovascular risk factors.   
Obesity implies increased body weight due to the enlargement of the adipose tissue to the 
extent that impairs health. Regional obesity appears to be an important indicator of the risk 
level. Thus, the diagnosis of obesity depends on three main aspects: relative weight (total 
body mass with relation to body height), total body fat, and fat distribution. 
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Body mass index (BMI) has been widely accepted as a simple and the most practical 
measure of fatness in clinical and epidemiological surveys, eventhough it doesn’t 
distinguish fat from lean body mass. In fact, it is an indicator of the nutritional status, not a 
measure of body fat mass. It has been shown that BMI≥25 kg/m2 is associated with 
increased morbidity, while BMI≥30 kg/m2 carries increased risk for both morbidity and 
mortality, primarily from diabetes and cardiovascular diseases (Irribaren et al., 1995). 
However, recent studies showed that BMI can be a reliable predictor of cardiovascular 
mortality only in severe obesity (Romero-Corral et al., 2006). The category of overweight 
people (BMI: 25-29.9 kg/m2) seems to be the most confusing, especially from the aspect of 
the therapeutic approach.  
BMI doesn’t provide sufficient information about fat mass. Therefore, body composition 
assessment is necessary for the diagnosis of obesity and prediction of its comorbidities. It 
discriminates individuals with true excess body fat from those with “normal weight 
obesity”, as well as from overweight individuals with normal body fat mass. Using a cut-off 
value of 30% body fat, Marques-Vidal et al. (2008) reported prevalence of “normal weight 
obesity” of 10.1% in women, and 3.2% in men, with increasing prevalence with aging.  
Specific fat distribution determines the risk level more accurately than the total body fatness 
per se. Excess adipose tissue in the abdominal region is more hazardous than the overall 
obesity, due to higher visceral fat deposition. Furthermore, it is associated with greater risk 
of cardiovascular diseases, metabolic disorders and type 2 diabetes mellitus (Després et al., 
1990; Molarius & Seidell, 1998). Central or abdominal obesity (firstly assigned as android 
type of obesity) has been identified as a risk factor for the cardiovascular diseases, as well as 
a symptom of metabolic syndrome. Normal weight subjects with higher visceral fat mass 
are at a higher risk (metabolically obese normal weight subjects). In addition, obese subjects 
with normal visceral fat mass can present with normal metabolic profile (metabolically 
healthy obese subjects) (Ruderman et al., 1998; Sims, 2001).      
2.1 Abdominal obesity 
It is well known that the risk of cardiovascular and metabolic abnormalities is determined 
by specific distribution of the adipose tissue. Abdominal (central) obesity is associated with 
dyslipidemia, impaired fasting glucose, insulin resistance and hypertension, which result in 
increased risk of cardio- and cerebrovascular diseases, and consequently premature death 
(Guzzaloni, 2009).   
Adverse effects of the abdominal obesity have been supported by many studies of the 
metabolism and endocrine activity of adipocytes from different regions of the abdominal 
adipose tissue. Abdominal fat includes two morphologically and functionally different 
depots: subcutaneous (superficial) and deep, visceral (intraabdominal). The latter is located 
in the abdominal cavity and includes intraperitoneal (omental and mesenterial) adipose 
tissue, which makes 80% of the intraabdominal fat mass, and retroperitoneal adipose tissue, 
which makes 20% of the intraabdominal fat mass (Misra&Vikram, 2003). Abdominal obesity 
can reflect expansion of either subcutaneous or visceral depot, or a combination of excess fat 
in both depots. However, visceral adipose tissue compartment has been considered more 
important in pathogenesis of the obesity complications. It is responsible for the development 
of insulin resistance, glucose intolerance and type 2 diabetes mellitus. According to Brochu 
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et al. (2000), visceral fat depot explains 10% of variability of insulin resistance and 16% of 
blood glucose. Visceral adipose tissue enlargement is mainly associated with lower values of 
HDL-cholesterol, elevated tryglicerides, apolipoprotein B (Couillard et al., 1996), as well as 
with elevated atherogenic lipoprotein subfractions and reduced concentration of HDL 
particles (Nakata et al., 2010). It positivly correlates with glucose intolerance and 
hyperinsulinemia (Wajchenberg, 2000), as well as the markers of the proinflammatory and 
prothrombotic state.   
Visceral adipose tissue function plays a crucial role in the development of metabolic 
abnormalities and insulin resistance, mainly due to the direct access of intraperitoneal 
adipose tissue to the liver through the portal circulation (Matsuzawa et al. 1995, Bosello & 
Zamboni, 2000). In comparison to the subcutaneous adipose tissue, visceral adipose tissue 
contains higher number of adipocytes per unit mass, higher number of endothelial cells in 
the stromal vascular fraction, higher β3-adrenoreceptor and α2-adrenergic receptor 
sensitivity, and it is better vascularized (Misra & Vikram, 2003; van Harmelen et al., 2004). 
Visceral adipocytes are more metabolically active, have higher lipolytic activity when 
stimulated by catecholamines, and are poorly responsive to the antilipolythic action of 
insulin. In addition, they secrete more proinflammatory (interleukin-6, interleukin-8, 
interleukin-1ǃ) and prothrombotic (plasminogen-acivator inhibitor-1) adipokines. Obesity is 
characterized by an increased number of β3- and decreased number of α2-adrenergic 
receptors, decreased insulin activity, increased activity of lipoprotein-lipase and acylation-
stimulating protein, with higher upload of triglycerides and lower postprandial suppression 
of lipolysis (Wajchenberg, 2000; van Herpen & Schrauwen-Hinderling, 2008). All of the 
above mentioned changes in the visceral adipose tissue provide increased release of free 
fatty acids and their flux towards the liver, where they induce gluconeogenesis, synthesis of 
triglycerides and apolipoprotein-B rich lipoproteins, as well as impairment of insulin action 
(Lonnquist et al., 1995, Freedland, 2004). Free fatty acids also exhibit proarrhythmic 
properties which explains association between the visceral fat and sudden death (Empana et 
al. 2004). On the other hand, obese adipose tissue is characterized by impairment of blood 
flow, development of hypoxia and local inflammation, infiltration by macrophages, and by 
disturbances in secretion of adipokines, which all together result in insulin resistance and 
systemic inflammation (Berg & Scherer, 2005; Coppack, 2005; Goossens, 2008). 
Computerized tomography (CT) and magnetic resonance imaging (MRI), performed at the 
L4-L5 level, are the most reliable anatomical methods for abdominal fat assessment, since 
they discriminate between the subcutaneous and the visceral fat depots (van der Kooy et al., 
1993). However, these methods are expensive, not feasible and unportable, which makes 
their use in clinical and epidemiological practice limited. Anthropometric parameters are 
more suitable as they are inexpensive, non-invasive and simple. Besides, most of them show 
a strong correlation with visceral abdominal fat size. 
2.1.1 Anthropometric parameters of abdominal obesity 
Several anthropometric indicators of abdominal obesity have been developed to measure 
abdominal adipose tissue mass. Some of them are presented in the form of ratios, especially 
the ones that incorporate body height, which gives more realistic picture of body 
proportions. On the other hand, it is difficult to interpret them biologically (Bouchard et al., 
1990). Many studies have compared them in order to demonstrate advantages of a particular 
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parameter in predicting the risk and visceral fat mass. As a rule, an ideal anthropometric 
measure of abdominal adiposity should predict individual cardiometabolic risk and clearly 
show effects of different preventative and therapeutic approaches. 
Waist-to-hip and waist-to-thigh ratios (WHR and WTR, respectively) were originally 
proposed as the key determinants of android and gynoid obesity (Krotkiewski et al., 1983; 
Molarius & Seidell, 1998). WHR has been most commonly used in identifying abdominal fat 
distribution. Waist circumference alone has received more attention in management of 
obesity since it requires only one measurement. It showed to be a better predictor of visceral 
fat volume and related cardiovascular risk profile than WHR (Després et al., 1991; Pouilot et 
al., 1994; Vissher et al., 2001; Wajchenberg, 2000; Logfren et al., 2004). Moreover, changes in 
waist circumference better reflect changes in cardiovascular risk factors. It is widely 
accepted as a surrogat marker of abdominal fat. On the other hand, waist circumference has 
been criticized for measuring both visceral and subcutaneous adipose tissues (Molarius & 
Seidell, 1998). Other studies suggest waist-to-height ratio (WHTR) as the better marker 
because it correlates highly with cardiometabolic risk factors (Hsieh & Yoshinaga, 1995; 
Ashwell, 2005). Conicity index, which is based on cylindrical shape of the body, has also 
been introduced as a potentially useful measure of abdominal adiposity (Valdez, 1991). 
However, it is considered to be very complex because it requires calculations from several 
different anhropometric values (Molarius & Seidell, 1998). 
Sagittal abdominal diameter (SAD), or abdominal height was first demonstrated by Kvist et 
al. (1988) to be a good correlate of visceral adipose tissue volume, observed by CT. Sjöstrom 
et al. (1994) proposed the use of sagittal abdominal diameter in the assessment of visceral fat 
mass. Soon after, Richelsen and Pedersen (1995) confirmed its value in assessing the 
abdominal fatness and prediction of the metabolic risk profile. 
3. Sagittal abdominal diameter – Visceral fat measure and cardiovascular risk 
predictor 
First measures of SAD were done on CT images and showed good predictive values in the 
assessment of visceral adipose tissue volume (Kvist et al., 1988). SAD, thus, may be a reliable 
represent of the visceral fat size. Moreover, two recent studies confirmed that SAD was a 
stronger predictor of metabolic syndrome than the whole visceral fat area (Valsamakis et al., 
2008; Hoenig, 2010), which could pointed to functionally different adipose tissue in the 
midline.  
External, anthropometric measurement of SAD is usually done using Holtain-Kahn 
abdominal caliper, at the level of the iliac crest, which approximates to the L4-L5 interspace 
(Figure 1). Since it has been proposed, SAD has been considered as more closely related to 
visceral fat mass than the other anthropometric measures beacuse it is measured in a supine 
position, when a subcutaneous fat is moved to the sides of the waist (van der Kooy et al., 
1993; Mukunddem-Petersen, 2006; Sampaio et al., 2007). Measuring SAD in that position 
reflects the width of intraabdominal fat in the antero-posterior plane, like on CT or MRI 
images. At the same value of SAD, an increase of waist circumference may reflect increase of 
subcutaneous adipose tissue size.  
Many studies confirmed strong association between anthropometrically assessed SAD and 
visceral adipose tissue area. Anjana et al. (2004), Sampaio et al. (2007) and Yim et al. (2010) 
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reported stronger correlation between SAD and visceral fat area, comparing to waist 
circumference. Zamboni et al. (1998) found better association between SAD and visceral fat 
area in lean and moderately overweight subjects than in the obese. Regarding to gender, some 
studies have found better correlation in men, ranged between 0.61 and 0.82 (van der Kooy et 
al., 1993; Zamboni et al., 1998), while others have reported stronger relationship in women, 
with the range between 0.52 and 0.87 (Pouilot et al., 1994, Sampaio et al., 2007). Some studies 
demonstrated that SAD is a better predictor of visceral fat than waist circumference in men 
(Després et al., 1991; van der Kooy et al., 1993), while others gave opposite results in women 
(Sampaio et al., 2007). In the MRI study, van der Kooy et al. (1993) showed that SAD was 
superior to waist circumference and WHR in assessing visceral fat mass changes in men, while 
waist circumference and WHR were better measures in women.  
    
Fig. 1. Measurement of sagittal abdominal diameter (horizontal section of abdomen) 
Comparing to other anthropometric measures, like waist circumference or WHR, SAD has 
been showed to have better correlation with biochemical and hemodynamic parameters 
associated with cardiovascular diseases and metabolic syndrome in both, lean and obese 
subjects: 
• Higher values of SAD correlate with atherogenic lipid profile including elevated 
triglycerides, reduced HDL-cholesterol, elevated apolipoprotein B levels, and 
atherogenic lipoprotein subfractions (Pouilot et al., 1994; Sjöstrom, 1994; Richelsen & 
Pedersen, 1995; Öhrvall et al., 2000; Turcato et al., 2000; Sampaio et al., 2007; Petersson 
et al., 2007; Nakata et al., 2010). 
• SAD is an important factor in prediction of glucose intolerance and insulin resistance 
(Pouliot et al., 1994; Öhrvall et al., 2000; Gustat et al., 2000; Risérus et al., 2004; Mazzali 
et al., 2006; Vasques et al., 2009a). Risérus et al. (2004) found that SAD was a strong 
predictor of hyperproinsulinemia, higher values of C-peptide and lower levels of 
insulin-like growth factor (IGF) binding protein-1.  
• SAD highly correlates with inflammatory and prothrombotic markers, like CRP 
(Mazzali et al., 2006; Petersson et al. 2007; Nakata et al., 2010) or PAI-1 (Öhrvall et al., 
2000). According to Petersson et al. (2007), every one-centimetre increase in SAD is 
followed by an increase of C-reactive protein (CRP) by 0.41 mg/L. The same authors 
SAD 
Visceral 
adipose tissue
Subcutaneous 
adipose tissue
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suggested that SAD may carry information concerning inflammatory status and 
possibly insulin resistance beyond that of other measures of obesity and fat distribution. 
• SAD is associated with blood pressure and predicts hypertension (Öhrvall et al., 2000; 
Strazzulo et al., 2001). Gustat et al. (2000) highlight that SAD can predict blood pressure 
when other measures cannot. 
• Among adipokines, SAD correlates with leptin and adiponectin blood levels (Mazzali 
et al., 2006); it also correlates with 11β-hydroxysteroid dehydrogenase-type 1 (11β-HSD-
1) mRNA expression in visceral adipose tissue, which is known to be associated with 
features of metabolic syndrome (Desbriere et al., 2006).  
Our previous results showed significantly higher values of SAD in obese women who 
displayed lipid and lipoprotein disturbances and hyperinsulinemia, comparing to healthy 
normal-weight women (Stokić et al, 1996, Stokić & Ivković-Lazar, 1996). According to our 
unpublished results (a group of 1090 men and 1231 women of different BMI-values, aged 
18-79 years), SAD showed a significant correlation with sistolic and diastolic blood pressure 
and glycaemia in both genders, and with total cholesterol and triglycerides in men. In both, 
men and women, SAD showed best correlation with diastolic blood pressure (men: r=0.340, 
women:r=0.198). By discriminative analysis we determined range of SAD that correspond 
with lowest risk (men: 20.12-24.97 cm; women: 19.85-24.75 cm), while extremely high values 
were in the following ranges: 32.58-34.65 cm (men) and 29.87-31.80 cm (women).   
In the large longitudinal study, Iribarren et al. (2006) confirmed utility of SAD in prediction 
of cardiovascular risk, independently of body mass index. Reed et al. (2003) found 
association between SAD and carotid artery intima-media thickness.  
Empana et al. (2004) established that age-adjusted risk of sudden death increases linearly 
with SAD increasement in both, normal-weight and overweight men. SAD has been shown 
to be an independent risk factor for death and morbidity in patients in the intensive care 
unit (Paolini et al., 2010). 
There are also two indexes derived from SAD: 
• SAD-to-body height ratio (SAD/H) has been showed as slightly better predictor than 
SAD alone. Kumlin et al. (1997) reported that SAD/H is a strong predictor of 
Framingham coronary risk score.  
• SAD to mid-thigh circumference ratio, or abdominal diameter index (ADI), has been 
proposed by Kahn (1993) as even better predictor of cardiovascular risk, which was 
confirmed by Smith et al. (2005).     
3.1 Application of sagittal abdominal diameter in elderly 
Aging process is characterized by body composition changes that could not be captured by 
standard anthropometric measures like BMI. Increasing of total body fat occurs in both 
genders, which is followed by decreasing of muscle mass (sarcopenic obesity) and body fat 
redistribution in terms of changes from peripheral to central (abdominal) pattern (Prentice & 
Jebb, 2001; Greenlund & Nair, 2003; Davidson & Getz, 2004). In women, menopause plays 
important role in transitioning from a premenopausal gynoid (gluteo-femoral) to a 
postmenopausal central (visceral) pattern of body fat distribution and increase in total body 
fat (Movsesyan et al., 2003). Even in early menopause women have a 49% greater visceral fat 
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mass comparing with premenopausal women (Toth et al., 2000). Together with other 
physiological and life style changes caused by aging, age-associated central fat distribution 
contributes to cardiovascular morbidity and mortality. That is why is highly recommended 
to assess central adiposity in older persons (Dorner & Rieder, 2011).    
Some evidences pointed to better predictive value of SAD in younger individuals (Iribarren 
et al., 2006, Mukuddem-Petersen et al., 2004). However, SAD could be also very useful 
indicator in the elderly. According to Turcato et al. (2000), SAD and waist circumference are 
the anthropometric parameters which are the most closely related to cardiovascular risk 
factors in women and men aged from 67 to 78 years, independently of BMI. Harris et al. 
(2000) and Snijder et al. (2002) found that SAD was even better predictor of visceral fat area 
in subjects older than 70 years, comparing to waist circumference, while Mukuddem-
Petersen et al. (2004) indicated that SAD had no advantages over simpler and more 
commonly used anthropometric measures such as waist circumference, regarding to their 
associations with components of the metabolic syndrome in older subjects.  
3.2 Gender and ethnic specific usage of sagittal abdominal diameter  
Men and women have different adipose tissue topography. Fat deposition is gluteo-femoral 
region is more typical for women, while men show preferential abdominal fat accumulation. 
Within abdominal region, visceral fat compartment is more predominant in men, while 
women have higher size of subcutaneous fat compartment (Anjana et al., 2004). Men and 
women also have different dynamics of losing visceral and subcutaneous fat during weight 
loss - men lose more visceral, and women lose more subcutaneous fat (van der Kooy et al., 
1993).  
It is assumed that SAD has a stronger capacity to predict visceral fat area, insulin resistance, 
and cardiometabolic risk in men, because they have higher visceral fat mass (Risérus et al., 
2004). Vasques et al. (2009b) confirmed its greater ability to identify insulin resistance in 
men. However, according to the results given by Mukuddem-Petersen et al. (2004) SAD is a 
stronger predictor of cardiovascular risk in women, while Duarte-Pimentel et al. (2010) 
recommend SAD as a marker of central adiposity preferentially in women.   
Some ethnic groups show different pattern of body fat distribution and different susceptibility 
to insulin resistance. For example, Asian Indians have greater abdominal fat mass than 
Europeans of the same nutrition level (Anjana et al., 2004), while middle-aged and older 
African-American men and women have lower visceral fat than Hispanic and white men and 
women (Carroll et al., 2008). There are race and ethnical differences in the relationship 
between body fat distribution and health risk factors; thus, anthropometric measures could 
differ regarding the predictive capacity of cardiovascular risk factors. However, according to 
the results of several studies, SAD seems to be an excellent marker of metabolic and 
cardiovascular risk factors, irrespectively of national origin or ethnic background (Hwu et al., 
2003; Valsamakis et al., 2004; Petersson et al., 2007, Iribarren et al., 2006).   
3.3 Treshold values for sagittal abdominal diameter – Reflection of critical visceral fat 
mass or cardiometabolic risk  
In spite of many evidences that SAD is very good in capturing the cardiometabolic risk, its 
use in clinical practice is limited due to a lack of specific cut-offs. Some authors have 
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proposed cut-off values for SAD using different criteria, usually its correlation with 
cardiometabolic parameters and visceral fat area (Table 1). These results were mostly 
obtained using Receiver Operating Characteristics (ROC) curves, or linear regression 
analysis, and vary from 19.3 cm (Sampaio et al., 2007) to 27.6 cm (Valsamakis et al., 2004). 
Our results were obtained using the principles of rough set theory that will be described 
below. They were derived from evaluation of relationship between SAD and cardiovascular 
risk factors.  
We produced “transparent”, semantic model which can be easily analyzed. The most 
important information which can be extracted from semantic models is concerned with the 
meaning and importance of its elements, as well as with the relations between them. Data 
were represented in the form of a table with rows containing the objects and columns 
containing the attributes, and model was produced in the multiple sets containing If – Then 
rules.  
 
SAD (cut-offs) Population Criterion Author 
≥25 cm Men/Women Association with multiple 
metabolic disorders 
Pouliot et al., 1994 
≥22.8 cm 
≥25.2 cm 
Men 
Women 
Corresponds to 130 cm2 of 
visceral fat area 
Lemieux et al., 1996 
≥27.6 cm Men Predictive value for 
metabolic syndrome 
Valsamakis et al., 2004 
≥23 cm Men  Predictive value for sudden 
death 
Empana et al., 2004 
≥20.5 cm  
≥19.3 cm 
 
Men  
Women 
 
Corresponds to 100 cm2 of 
visceral area 
Sampaio et al., 2007 
≥20 cm Men  Predictive value for insulin 
resistance  
Vasques et al., 2009a 
≥22.2 cm 
≥20.1 cm  
Men 
Women 
Predictive value for an 
elevated cardiometabolic 
risk score 
Risérus et al., 2010 
≥23.1 cm 
≥20.1 cm  
Men 
Women 
Corresponds to altered 
waist circumference (>102 
cm for men and >88 cm for 
women) 
Duarte Pimentel et al., 
2010 
≥24.3 cm Men/Women 
Corresponds to increased 
cardiovascular risk in 
overweight and obese 
individuals 
Stokić et al., 2010 
Table 1. Recommended cut-off values for SAD 
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4. Model for the better applicability of SAD in identifying patients at higher 
cardiovascular risk 
Modern healthcare and computer science are fields that are interlaced to form the field of 
medical informatics. As mentioned by Øhrn (1999), Blois and Shortliffe define medical 
informatics as “the rapidly developing scientific field that deals with the storage, retrieval 
and optimal use of biomedical information, data, and knowledge for problem solving and 
decision making.” In its broadest sense, medical informatics can be said to concern itself 
with the management of information in the context of modern healthcare. According to 
Øhrn (1999) current research in the field of medical informatics covers a wide array of 
topics, including: 
• Data acquisition: Capturing and recording of the medical data usually include things 
that are not easily recorded or precisely defined. 
• Medical vocabularies: Medical data has to be represented in machine-readable form. 
• Electronic medical records: An electronic medical record has to be searchable. Its 
content should be structured internally. 
• Decision support systems: These are computer programs that help clinicians make 
clinical decisions. 
• Deployment barriers: The barriers of deployment may be technical, operational, 
organizational and legal nature. Often, systems that may prove successful in research 
settings do not make it into clinical use. 
• Confidentiality issues: Medical information is often sensitive and with a potential for 
misuse by third-parties. 
Obviously, as a main prerequisite there is a existence of medical dataset or database. 
Medical datasets are often described as incomplete, sparse, vague, fuzzy, etc. According to 
Greco et al. (1998), the rough sets theory has often proved to be an excellent mathematical 
tool for the analysis of a vague description of objects. 
On the base of the table-organized data it is possible to produce semantic model which 
provides information about meaning and importance of its elements, as well as the 
relationship between them (Brtka et al., 2008; Stokić et al., 2010). In order to investigate 
relationship between SAD and anthropometric and cardiovascular risk factors, we used 
methodology based on rough set theory (Pawlak et al, 1995, Pawlak & Skowron, 2007) 
applied to table–organized data with producing decision rules in the If -Then form.  
Our study included 1334 subjects (700 women and 634 men), aged 43.49±10.43 years.  
Following parameters were analyzed: age (years), body mass index (kg/m2), SAD (cm), 
body fat mass (%), systolic and diastolic blood pressure (mmHg), total-, LDL- and HDL-
cholesterol (mmol/L), triglycerides (mmol/L), fasting plasma glucose (mmol/L), fibrinogen 
(g/L), uric acid (μmol/L), and 10-year Framingham Risk Score. The experiments were 
conducted by software system Rosetta - A Rough Set Toolkit for Analysis of Data. All numerical 
attributes were discretized using a simple “equal frequency binning” technique. The 
attribute SAD was chosen to be the decision attribute while all remaining attributes were 
chosen to form the set of condition attributes and the set of rules containing rules in the If – 
Then form was generated. The decision attributes (SAD) were classified into three classes:  
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• 13.00-24.2 cm,  
• 24.3-31.6 cm and 
• 31.7-36.2 cm.  
4.1 Rough-set theory principles 
As the mathematical basis of the rough set theory there is the indiscernibility relation. Every 
object of the universe is described by certain amount of information expressed by means of 
some attributes used for that object description. The objects characterized by the same 
information are indiscernible in view of the available information about them. 
As in Greco et al. (1998), Øhrn (1999) and Pawlak & Skowron (2007), let U be a universe 
(finite set of objects), Q={q1,q2,...,qm} is a finite set of attributes, Vq is the domain of attribute q 
(attribute values) and V is the union of Vq for every q∈Q. An information system is the 4-
tuple S=(U,Q,V,f) where f is a function such that f(x,q)∈Vq  for each q∈Q, x∈U, called 
information function. 
Let x,y∈U (x and y are two objects e.g. patients), f is an information function and q∈Q. Every 
non–empty subset of attributes P determines an indiscernibility relation on U, denoted by 
 {( , ) : ( , ) ( , ), }PI x y U U f x q f y q q P= ∈ × = ∀ ∈  (1) 
The IP is an equivalence relation. The family of all the equivalence classes of the IP is denoted 
by U/IP  and the equivalence class containing an element x by IP(x). 
Let us consider a simple example of an information system based on the example from 
Greco et al. (1998), see Table 2.  
 
Object Age Body Mass (BM) Systolic blood pressure SAD 
x1 young good low low 
x2 middle-age medium low high 
x3 middle-age medium low low 
x4 old medium low high 
x5 middle-age good high high 
x6 young medium high low 
Table 2. Simple example of an information system 
In the given table, there is a universe of six objects U={x1,...,x6} and each object is described 
by means of four attributes: Age, Body Mass, Systolic Blood Pressure (SBP) and SAD. 
If P={Age,BM,SBP} then, by (1), we have: IP={(x1,x1), (x2,x2), (x2,x3), (x3,x2), (x3,x3), (x4,x4), (x5,x5) 
(x6,x6)}, U/IP={{x1}, {x2,x3}, {x4}, {x5}, {x6}}. 
4.1.1 The definition of the rough set 
The rough set theory proved to be an excellent mathematical tool for the analysis of data in 
various domains. The information about the real world is given in a form of a decision 
system. The next definitions are based on Pawlak et al. (1995), Greco et al. (1998), Øhrn 
(1999) and Pawlak & Skowron (2007). 
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Let C⊂Q and D⊂Q  so that C∩D=∅, where Q is a set of attributes. The attributes from C are 
called the condition attributes and the attributes from D are called the decision attributes. 
An information system where the set of condition attributes and the set of decision 
attributes are defined is called the decision system. 
In most cases there is usually one binary decision attribute, while the other attributes are the 
condition attributes. In the previous example P might be the set of the condition attributes, 
and the set of decision attributes contains one element: D={SAD}. 
Let X  be a non–empty subset of U  and ∅ ≠ P ⊆ Q. The set X is approximated by means of 
P–lower (2) and P–upper (3) approximations of X: 
 ( ) { : ( ) }PP X x U I x X= ∈ ⊆  (2) 
 ( ) ( )P
x X
P X I x
∈
=   (3) 
The P–boundary region Bn(X) of X is defined by: 
 ( ) ( ) ( )Bn X P X P X= −  (4) 
For example, let us consider a case when the set X contains only those elements where the 
value of the decision attribute SAD is low: X={x1,x3,x6} (Table 2). Now, we can approximate 
the set X using only the information contained in P by constructing the P–lower (2) and P–
upper (3) approximations of X: 
1 6( ) { , }P X x x= , 
1 2 3 6( ) { , , , }P X x x x x= . 
The P–boundary region (4) of X is:  
2 3( ) { , }Bn X x x= . 
The reader may notice that the objects x2 and x3 have exactly the same values of the 
condition attributes but different value of the decision attribute. So, they constitute 
boundary region. We can say that the rough sets can be defined as follows (Pawlak et al., 
1995; Pawlak & Skowron, 2007):  
The set X is rough (inexact) with respect to IP, if the boundary region of X is nonempty. The 
set X is crisp (exact) with respect to IP, if the boundary region of X is empty. 
4.1.2 Data reduction 
If we manage to identify equivalence classes then some savings (reductions) are to be made 
since only one element of the equivalence class is needed to represent the entire equivalence 
class. An issue of practical importance in reduction is to keep only those attributes that 
preserve the indiscernibility relation and consequently, the set approximation. The rejected 
attributes are redundant (superfluous) since their removal cannot worsen the classification 
(Greco et al., 1998). 
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Let ∅ ≠ P ⊆ Q  and a∈P. Attribute a is superfluous in P if IP=IP-{a}. 
For example, if R= {Age, BM}, S= {Age, SBP}, and T= {BM, SBP} (Table 2), then it is obvious 
that IR=IP and IS=IP while IT≠IP. This means that R and S are reducts of P, while T is not. The 
attribute Age is indispensable, but the attributes BM and SBP may be mutually exchanged. 
This means that it is enough to use reduct {Age, BM} to estimate the value of the decision 
attribute SAD. In the analog case we can use the reduct {Age, SBP} to estimate the value of 
decision attribute SAD, but we can not use the reduct {BM, SBP}. 
The calculation of all reducts is very complex but in many practical applications it is not 
necessary to calculate all the reducts, but only some of them. 
4.1.3 Discretization 
If we want numerical attributes to be properly incorporated into the classification rules, we 
should to discretize them. This enables the numerical attributes to be treated as categorical 
ones, and several algorithms for this purpose are available (Greco et al., 1998; Øhrn, 1999). 
The goal of the discretization process is to search for intervals or bins, where all cases that 
fall within the same interval are grouped together. This process can be also seen as the 
process of classification of the attributes’ value set to some classes. The discretization is not 
specific to the rough set approach but is a pre – required step and is often performed 
implicitly, behind the scene, using human expert knowledge. 
4.1.4 Decision rules 
The expression a = v, where a is an attribute and v is an attribute value is called the 
descriptor. Now, it is possible to investigate the rules of the form: If ǂ Then ǃ. Here ǂ denotes 
a conjunction (AND logical operator) of descriptors that only involve attributes of some 
reduct (rule’s antecedent) and ǃ (rule’s consequent) denote a descriptor d = v, where d is a 
decision attribute and v is the allowed decision value. 
For example, if we use the reduct R={Age, BM} from Table 2 and SAD as a decision attribute, 
then it is possible to generate the rules with two descriptors in the antecedent part and one 
descriptor in the consequent part of the rule. It is important to notice that a shorter reduct 
set means shorter decision rules in the rule set generated from that reduct. 
4.2 Application of rough-set theory in identification of patients at higher 
cardiovascular risk using SAD 
Our results showed that SAD could be a clinically useful marker for identification of 
combination and structure of risk factors by applying different rules in individuals of 
different BMI-categories.  
Lower values of SAD in normal-weight individuals younger than 50 years always 
corresponded with Framingham risk score <9. However, in normal-weight subjects older 
than 50 years, SAD couldn’t identify those at lower risk. SAD values between 24.3 and 31.6 
cm, or even lower, between 13.0 and 24.2 cm, corresponded with Framingham risk score 
between 9 and 14 (Table 3). It is in agreement with observations which indicate a 
centralization of adipose tissue with aging, irrespective of BMI. This would represent a 
category of metabolically obese normal weight individuals.     
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According to these results, measurement of SAD is not enough for identification of 
cardiovascular risk in normal-weight individuals. In that regard, it is necessary to include 
other methods of fat mass assessment, like CT or MRI.  
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<41 
<28.92 <123 >88 <5.37 1.4-2.19 <3.24 1.01-1.21 <4.7 3.06-3.76 273-344 <9 
13.0-24.2 
<28.92 123-141 >88 >6.51 <1.4 <3.24 <1.01 4.7-5.4 >3.76 <273 <9 
41-50 
<28.92 <123 78-88 <5.37 <1.4 3.24-4.0 <1.01 <4.7 <3.06 <273 <9 
<28.92 123-141 >88 <5.37 >2.19 <3.24 <1.01 4.7-5.4 >3.76 <273 <9 
<28.92 <123 78-88 >6.51 1.4-2.19 >4.00 >1.21 >5.4 3.06-3.76 <273 <9 
>50 <28.93 123-141 >88 >6.51 >2.19 3.24-4.0 >1.21 4.7-5.4 3.06-3.76 273-344 9-14 
13.0-24.2 
OR 
24.3-31.6 
Table 3. Obtained rules for normal-weight subjects (BMI<26.43 kg/m2) 
By examining the decision rules, SAD could point out a group of overweight patients with 
high level of visceral fat with different combination and composition of cardiovascular risk 
factors (Table 4). Thus, in overweight individuals aged 41-50 years, with higher fat mass, 
and SAD between 24.3 and 31.6 cm, we could expect higher values of diastolic blood 
pressure, total- and LDL-cholesterol, triglycerides, uric acid, as well as Framingham risk 
score over 14. The same range of SAD in older overweight individuals (>50 years) with 
higher fat mass, include higher systolic blood pressure, fasting plasma glucose and 
fibrinogen. On the other side, in younger overweight subjects with lower SAD (<24.3 cm) we 
could expect lower values of all atherogenic parameters, higher values of HDL-cholesterol 
and Framingham risk score <9, even if they have higher fat mass. 
It means that SAD could identify metabolically healthy overweight individuals.  
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<41 >39.71 <123 <78 <5.37 <1.4 <3.24 >1.21 4.7-5.4 >3.76 >344 <9 13.0-24.2 
41-50 
>39.71 <123 >88 >6.51 >2.19 <3.24 1.01-1.21 >5.4 >3.76 >344 9-14 
13.0-24.2 
OR 
24.3-31.6 
28.92-39.71 <123 >88 >6.51 <1.4 >4.0 1.01-1.21 <4.7 >3.76 >344 9-14 
>50 
<28.92 123-141 >88 5.37-6.51 >2.19 <3.24 >1.21 4.7-5.4 >3.76 <273 9-14 
<28.92 <123 78-88 >6.51 1.4-2.19 >4.00 1.01-1.21 >5.4 >3.76 273-344 9-14 
<41 <28.92 123-141 78-88 <5.37 <1.4 <3.24 >1.21 4.7-5.4 3.06-3.76 >344 <9 
24.3-31.6 
41-50 
28.92-39.71 <123 >88 >6.51 >2.19 >4.00 1.01-1.21 4.7-5.4 <3.06 >344 >14 
>39.71 123-141 >88 >6.51 <1.4 >4.00 >1.21 <4.7 3.06-3.76 <273 9-14 
>50 
28.92-39.71 >141 >88 >6.51 >2.19 >3.24 1.01-1.21 >5.4 3.06-3.76 273-344 9-14 
28.92-39.71 >141 >88 >6.51 >2.19 >4.00 >1.21 <4.7 <3.06 <273 9-14 
 
 
Table 4. Obtained rules for overweight subjects (BMI: 26.43-32.52 kg/m2) 
As it is displayed in the Table 5, SAD values above 31.7 cm in obese subjects always 
correspond to Framingham risk score >14. Younger obese individuals (<41 years) with 
lower values of SAD usually are at the lower cardiovascular risk (metabolically healthy 
obese individuals).   
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<41 
>39.71 <123 <78 <5.37 >2.19 <3.24 1.01-1.21 4.7-5.4 3.06-3.76 <273 
<9 
13.0-24.2 
>39.71 <123 >88 <5.37 <1.4 3.24-4.00 1.01-1.21 <4.7 3.06-3.76 >344 
28.92-39.71 123-141 >88 >6.51 1.4-2.19 >4.00 >1.21 >5.4 >3.76 >344 >14 
41-50 >39.71 123-141 >88 >6.51 >2.19 3.24-4.00 >1.21 4.7-5.4 <3.06 >344 9-14 
<41 
>39.71 <123 78-88 5.37-6.51 <1.4 >4.00 >1.21 4.7-5.4 >3.76 >344 
<9 
24.3-31.6 
>39.71 <123 <78 <5.37 <1.4 <3.24 <1.01 <4.7 3.06-3.76 <273 
>39.71 123-141 >88 <5.37 <1.4 <3.24 >1.21 4.7-5.4 3.06-3.76 >344 
>39.71 <123 <78 <5.37 <1.4 <3.24 <1.01 <4.7 3.06-3.76 <273 
>39.71 123-141 >88 >6.51 1.4-2.19 3.24-4.00 <1.01 4.7-5.4 3.06-3.76 273-344 9-14 
>50 >39.71 123-141 78-88 5.37-6.51 1.4-2.19 <3.24 1.01-1.21 4.7-5.4 3.06-3.76 >344 >14 
41-50 >39.71 >141 >88 5.37-6.51 >2.19 3.24-4.00 <1.01 >5.4 3.06-3.76 273-344 >14 24.3-31.6 
OR 
31.7-36.2 >50 28.92-39.71 123-141 >88 >6.51 <1.4 3.24-4.00 >1.21 >5.4 >3.76 273-344 9-14 
<41 >39.71 123-141 78-88 >6.51 >2.19 3.24-4.00 <1.01 >5.4 >3.76 >344 >14 
31.7-36.2 
>50 >39.71 >141 >88 >6.51 >2.19 >4.00 >1.21 >5.4 >3.76 >344 >14 
Table 5. Obtained rules for obese subjects (BMI>32.52 kg/m2) 
5. Conclusion 
Many studies have proved that SAD is a good predictor of abdominal, especially visceral, 
fat mass, as well as of cardiometabolic risk. Several authors have suggested specific cut-off 
values for SAD that corresponded with cardiovascular and metabolic risk or with visceral 
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fat area obtained by CT. Using the concept of a rough set, proved as a formal tool for 
modeling and processing information systems, we developed a useful model for 
identification of individuals with multiple cardiovascular risk factors using SAD.  
Our results revealed connection between SAD and cardiovascular risk factors which showed 
dependence on age and nutrition level. We primarily recommend application of SAD in the 
assessment of the cardiovascular risk in overweight and obese individuals. SAD values 
≥24.3 cm in overweight and obese subjects older than 41 years should correspond to 
increased risk, while values <24.3 cm in overweight subjects younger than 41 years could 
point to healthy metabolic profile.  
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